Imatinib Mesylate (Gleevec)

Imatinib mesylate · Novartis

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Imatinib Mesylate (Gleevec), covering 2010-04-09 to 2016-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer [Phase 2]